Addressing Racial Inequities in US Cancer Clinical Trials
- In a recent Phesi analysis of 589,295 patients participating in 6,372 United States cancer clinical trials over the last 15 years, researchers found that 42% of the African American population and 48% of the Latin American population in these trials lacked representation. These results highlight severe diversity issues in the US clinical development design and recruitment process....
